2021 Annual Meeting | C35 - Update in Movement Disorders 2
Program Materials Program Evaluations
06:00 PM - 06:25 PM EDT | Speaker |
Novel Pharmacological Approaches for Tourette Syndrome
Tamara M. Pringsheim, MD, FAAN |
06:25 PM - 06:50 PM EDT | Speaker |
Deep Brain Stimulation, Focused Ultrasound, and Non-neurosurgical Interventions for Parkinson's Disease
Gian D. Pal, MD |
06:50 PM - 07:00 PM EDT | Q&A |
Live Q&A
Tamara M. Pringsheim, MD, FAAN, Gian D. Pal, MD |
Tamara M. Pringsheim, MD, FAAN | The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator. |
Gian D. Pal, MD | Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CLRM Law. Dr. Pal has stock in Baudax Bio. The institution of Dr. Pal has received research support from National Institutes of Health. The institution of Dr. Pal has received research support from Parkinson's Foundation. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with RKV Firm. |